5 hours All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy Zacks
Vivos Therapeutics (VVOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
X